Vinge advised Cantargia AB (publ) in connection with a directed share issue of SEK 564 million to a…
Vinge advises Re:NewCell AB in connection with its listing on Nasdaq First North Premier Growth Mark…
Vinge has acted for Ellevio in connection with its acquisition of the shares in Elektra Nät AB, an e…
Cantargia AB (publ) makes a directed share issue of approximately SEK 410 million to a number of Swe…
Vinge has advised Lifco AB in connection with its establishment of an MTN program with a framework a…
Vinge advised Fastighets AB Trianon in connection with a directed share issue of SEK 210 million thr…
Vinge has assisted Nuevolution AB (publ) (“Nuevolution”) in connection with the cash offer to the sh…
Cantargia AB (publ) makes a directed share issue of approximately SEK 106 million to a number of Nor…
AB Fagerhult (publ) has entered into an agreement to acquire iGuzzini illuminazione S.p.A. for EUR 3…
Vinge advised Medivir AB (publ) in connection with a directed share issue of SEK 155 million through…
Vinge has advised Wilson Therapeutics on a directed new issue of shares, whereby Wilson Therapeutics…
Vinge has advised Tempest Security AB (publ) in connection with its listing on Nasdaq First North. T…
Vinge advises Infant Bacterial Therapeutics AB (publ) (Nasdaq First North Premier) in connection wit…
Vinge advises Cantargia AB (publ) (Nasdaq First North) in connection with a combined directed issue…
Vinge advises Medicover AB (publ) (“Medicover”) and its main shareholder Celox Holding AB (“Celox”),…
Vinge has advised Platzer Fastigheter in conjunction with the acquisition of AB Volvo’s real estate…
